SETD2 and pancreatic neoplasm: In addition, SETD2 loss may be associated with pancreatic cancer because its loss leads to the ectopic expression of H3K27me3 and H3K27ac, which would contribute to the occurrence of immune escape in pancreatic ductal carcinoma 24-25.